Evidence map›Paper›PMID 38764627›Full record

ArticleACS omega2024

Siyi Zhang, Lingli Huang, Youjie Zeng, Ge Gao, Hui Wu, Dai Li, Ren Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siyi ZhangDepartment of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Lingli HuangDepartment of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Youjie ZengDepartment of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Ge GaoDepartment of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Hui WuDepartment of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Dai LiPhase I Clinical Tria Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Ren GuoDepartment of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.ORCID https://orcid.org/0000-0002-3930-6846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have revealed that abnormal expressions of membrane transporters were associated with colorectal cancer (CRC). We herein performed a comprehensive bioinformatics analysis to identify the key transporter protein-related genes involved in CRC and potential mechanisms. Differentially expressed transporter protein-related genes (DE-TPRGs) were identified from CRC and normal samples using The Cancer Genome Atlas database. SLC38A3 expression was validated by immunohistochemistry and RT-qPCR, and the potential mechanism was explored. A total of 63 DE-TPRGs (29 up-regulated and 34 down-regulated) were screened. Inside,

Identifiers

PMID38764627
PMCPMC11097367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.